Display options
Cite
Tan Z, Liu W, Liu H, et al. Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43]. Eur J Pharm Biopharm. 2019;145:96-97doi: 10.1016/j.ejpb.2019.10.006.
Tan, Z., Liu, W., Liu, H., Li, C., Zhang, Y., Meng, X., Tang, T., Xi, T., & Xing, Y. (2019). Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43]. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 14596-97. https://doi.org/10.1016/j.ejpb.2019.10.006
Tan, Zhoulin, et al. "Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43]." European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V vol. 145 (2019): 96-97. doi: https://doi.org/10.1016/j.ejpb.2019.10.006
Tan Z, Liu W, Liu H, Li C, Zhang Y, Meng X, Tang T, Xi T, Xing Y. Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43]. Eur J Pharm Biopharm. 2019 Dec;145:96-97. doi: 10.1016/j.ejpb.2019.10.006. Epub 2019 Nov 07. PMID: 31735275.
Copy Download .nbib Format: NLM
Share it on

Eur J Pharm Biopharm. 2019 Dec;145:96-97. doi: 10.1016/j.ejpb.2019.10.006. Epub 2019 Nov 07.

Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43].

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Zhoulin Tan, Wei Liu, Hai Liu, Cheng Li, Yan Zhang, Xia Meng, Tingting Tang, Tao Xi, Yingying Xing

Affiliations

  1. School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  2. School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, People's Republic of China. Electronic address: [email protected].
  3. School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, People's Republic of China. Electronic address: [email protected].

PMID: 31735275 DOI: 10.1016/j.ejpb.2019.10.006

[No abstract available.]

Publication Types